0001209191-23-004068.txt : 20230119 0001209191-23-004068.hdr.sgml : 20230119 20230119174946 ACCESSION NUMBER: 0001209191-23-004068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230102 FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: von Moltke Lisa CENTRAL INDEX KEY: 0001808592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 23538398 MAIL ADDRESS: STREET 1: C/O SERESTHERAPEUTICS, INC. STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-02 0 0001346830 Cara Therapeutics, Inc. CARA 0001808592 von Moltke Lisa C/O CARA THERAPEUTICS, INC. 107 ELM STREET, 4 STAMFORD PLAZA STAMFORD CT 06902 1 0 0 0 Stock Option (Right to Buy) 10.74 2023-01-02 4 A 0 45841 0.00 A 2033-01-02 Common Stock 45841 45841 D The shares shall vest and become exercisable in twelve (12) equal quarterly installments beginning on November 1, 2022, in each case subject to the Reporting Person's continued service as of each such date. /s/ Darren DeStefano, Attorney-in-Fact 2023-01-19